Fortress Biotech, Inc. — Investor Relations & Filings

Fortress Biotech is an innovative biopharmaceutical company that acquires, develops, and commercializes pharmaceutical products. The company operates through a network of subsidiary and partner companies to advance a diversified portfolio. This portfolio includes revenue-generating commercial products, primarily in dermatology, and a robust pipeline of development-stage candidates. The clinical pipeline spans multiple therapeutic areas, including rare diseases, oncology, gene therapy, neurology, and pain management. Key development programs are focused on conditions such as Menkes disease, AL amyloidosis, and glioblastoma, utilizing advanced modalities like CAR-T cell therapies, oncolytic viruses, and gene therapies.